Home › NDC Lookup › RxCUI directory › RxCUI 727517

50 ML glucose 500 MG/ML Prefilled Syringe — RxCUI 727517

RxNorm drug concept · Semantic clinical drug
RxCUI 727517 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI727517
Official name50 ML glucose 500 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known as50 ML dextrose 50 % Prefilled Syringe; dextrose 50 % in 50 ML Prefilled Syringe; dextrose 25 GM per 50 ML Prefilled Syringe
FDA products mapped12
Package NDCs mapped13
Reported Medicaid activity (SDUD)3,650 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dextrose: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dextrose is essentially glucose — sugar — given directly into a vein. In an emergency, it's used to quickly raise dangerously low blood sugar, which can happen with too much insuli...
  • Specific formulations — Infant Dextrose (25%) and Dextrose (25% injection) — are FDA-approved to treat low blood sugar in newborns and infants up to 2 years old. That said, prematu...
  • Is dextrose safe for my baby or newborn?
  • The most common issues are high blood sugar, vein irritation or clotting at the IV site, low sodium in the blood, and infection. More serious — but less common — reactions include...
📖 Read our full Dextrose guide →

🕸️ Concept Web — How 50 ML glucose 500 MG/ML Prefilled Syringe Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 50 ML glucose 500 MG/ML Prefilled Syringe RxCUI 727517

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Glucose 4850
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glucose Prefilled Syringe 727516
    • Glucose Injectable Product 1165819
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Glucose 500 MG/ML 315790

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Glucose 500 MG/ML SCDC · 315790
  • Glucose Prefilled Syringe SCDF · 727516
  • Glucose Injectable Product SCDG · 1165819

📦 FDA Products & Package NDCs

12 products · 13 package NDCs
13 package NDCs map to RxCUI 727517 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00404-9845-50 1 SYRINGE in 1 BAG (0404-9845-50) / 50 mL in 1 SYRINGE Dextrose Henry Schein, Inc. 2022-01-10
00409-6648-02 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-6648-02) / 50 mL in 1... Dextrose Hospira, Inc. 2005-03-31
00409-7517-16 10 CARTON in 1 CONTAINER (0409-7517-16) / 1 SYRINGE, PLASTI... Dextrose Hospira, Inc. 2005-12-02
51662-1216-01 1 SYRINGE, PLASTIC in 1 CARTON (51662-1216-1) / 50 mL in 1... 50% DEXTROSE HF Acquisition Co LLC, DBA HealthFirst 2018-09-19
51662-1453-01 1 SYRINGE in 1 CARTON (51662-1453-1) / 50 mL in 1 SYRINGE DEXTROSE MONOHYDRATE HF Acquisition Co LLC, DBA HealthFirst 2020-01-11
51662-1584-01 1 SYRINGE in 1 CARTON (51662-1584-1) / 50 mL in 1 SYRINGE Dextrose monohydrate HF Acquisition Co LLC, DBA HealthFirst 2022-02-11
51662-1584-03 10 POUCH in 1 CASE (51662-1584-3) / 1 SYRINGE in 1 POUCH (5... Dextrose monohydrate HF Acquisition Co LLC, DBA HealthFirst 2022-02-11
70518-4219-00 10 CARTON in 1 CONTAINER (70518-4219-0) / 1 SYRINGE, PLASTI... Dextrose REMEDYREPACK INC. 2024-10-23
71872-7003-01 1 CARTON in 1 BAG (71872-7003-1) / 1 SYRINGE, PLASTIC in 1... Dextrose Medical Purchasing Solutions, LLC 2018-02-28
71872-7102-01 1 CARTON in 1 BAG (71872-7102-1) / 1 SYRINGE in 1 CARTON /... Dextrose Medical Purchasing Solutions, LLC 2018-03-05
71872-7282-01 1 SYRINGE in 1 BAG (71872-7282-1) / 50 mL in 1 SYRINGE Dextrose Monohydrate Medical Purchasing Solutions, LLC 2022-03-01
76329-3302-01 1 SYRINGE in 1 CARTON (76329-3302-1) / 50 mL in 1 SYRINGE Dextrose Monohydrate International Medication Systems, Limited 2021-11-11
84549-0517-16 50 mL in 1 SYRINGE, PLASTIC (84549-517-16) Dextrose ProPharma Distribution 2025-08-27
Observed labelers: HF Acquisition Co LLC, DBA HealthFirst (4) · Medical Purchasing Solutions, LLC (3) · Hospira, Inc. (2) · Henry Schein, Inc. (1) · International Medication Systems, Limited (1) · ProPharma Distribution (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.